Literature DB >> 18408869

A dual mechanism of 4-hydroxy-5-methyl-3[2H]-furanone inhibiting cellular melanogenesis.

Hyo Jung Kim1, Sang Mi An, Yong Chool Boo.   

Abstract

In previous studies, 4-hydroxy-5-methyl-3[2H]-furanone (HMF) was shown to have potent antioxidative and antimelanogenic effects, suggesting its potential use as a depigmenting agent. The present study investigated its mechanism of action on murine melanoma B16F10 cells stimulated by theophylline, an activator of the cyclic AMP/protein kinase A signaling leading to tyrosinase gene expression. When the cells were stimulated with theophylline, there were dose-dependent increases in cellular tyrosinase protein content and melanin formation, as expected. HMF inhibited the theophylline-stimulated melanin formation as effectively as arbutin, one of the most widely used depigmenting agents in cosmetics. HMF appeared to reduce tyrosinase mRNA and protein content in the cells stimulated by theophylline, indicating it inhibited tyrosinase gene expression. HMF also effectively inhibited tyrosinase-catalyzed melanin formation from dihydroxyphenylalanine in the cells as well as in vitro. Therefore, the antimelanogenic effects of HMF were best explained by a dual mechanism inhibiting tyrosinase gene expression and the enzyme activity of pre-existing tyrosinase.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18408869

Source DB:  PubMed          Journal:  J Cosmet Sci        ISSN: 1525-7886            Impact factor:   0.948


  2 in total

1.  Silencing of GPNMB by siRNA inhibits the formation of melanosomes in melanocytes in a MITF-independent fashion.

Authors:  Ping Zhang; Wei Liu; Cansheng Zhu; Xiaoying Yuan; Dongguang Li; Weijie Gu; Huimin Ma; Xin Xie; Tianwen Gao
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

2.  Isolation of resveratrol from vitis viniferae caulis and its potent inhibition of human tyrosinase.

Authors:  Jiaa Park; Yong Chool Boo
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-12       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.